Brighton Muronzereyi ZIMBABWE’s decades-long severe shortage of medicines in public hospitals is escalating, worsened by a crippling US$20 million government debt owed to the country’s primary medical supplier, the National Pharmaceutical Company (NatPharm). Appearing before the Parliamentary Portfolio Committee on Health on Tuesday this week, NatPharm managing director, Newman Madzikwa, described the national drug supplier’s…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions